WSI Co Ltd
KOSDAQ:299170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
KR |
|
Ferrovial SA
MAD:FER
|
ES |
Intrinsic Value
The intrinsic value of WSI Co Ltd (299170) under the Base Case is 697.45 KRW per share. Compared with the current market price of 1 303 KRW, the stock appears Overvalued by 46% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -7% last year to 6% by 2031. Revenue grows about 8% a year over the next five years, below its five-year pace of 14%. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What WSI Does
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
- Headquarters
- Korea KR
- IPO date
- Sep 21, 2018
Earnings Waterfall
WSI Co Ltd
The intrinsic value for WSI Co Ltd (299170) under the Base Case is 697.45 KRW.
Compared with the current market price of 1 303 KRW, the stock appears Overvalued by 46% .